Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase NA 6Phase 4 3Phase 1 3Phase 3 2Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 31Breast 7Thoracic 6Gastrointestinal 3Classical hematology 3Head & Neck 2CNS 2Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Anemia 30Neoplasms 21Febrile Neutropenia 19Venous Thromboembolism 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neutropenia 5Leukemia, Myeloid, Acute 5Colorectal Neoplasms 5Pulmonary Embolism 4Myelodysplastic Syndromes 4Leukemia 4Fever 4Anemia, Iron-Deficiency 4Venous Thrombosis 3Thrombocytopenia 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Hematologic Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Vitamin D Deficiency 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Sepsis 2Recurrence 2Postoperative Complications 2Lymphoma, Follicular 2Lymphoma 2Infections 2

Interventions

ferrous fumarate 1Pharmacokinetics 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Ovarian Neoplasms × Classical hematology × Clear all
NCT04861181 2025-05-22

NIRAPK

Hospices Civils de Lyon

Phase 4 Terminated
12 enrolled
Classical hematologyGynecologic

Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT04352439 2022-09-26

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Duke University

Phase 4 Completed
19 enrolled 10 charts
Classical hematologyGynecologic

Ovarian Neoplasms, Venous Thromboembolism

NCT01953107 2021-05-12

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

Sunnybrook Health Sciences Centre

Phase 4 Completed
200 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡